Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCO Financial Group was a boutique investment bank and financial advisory firm that specialized exclusively in the life sciences and healthcare sectors. Operating as the investment banking affiliate of SCO Capital Partners, the firm provided a range of services including private placements, merger and acquisition advisory, and strategic consulting for emerging biotechnology companies. The group was particularly known for its expertise in financing micro-cap and small-cap entities, often facilitating complex corporate restructurings and private investment in public equity (PIPE) transactions. Throughout its operation, SCO Financial Group played a pivotal role in the capitalization of several clinical-stage companies focused on oncology, diagnostics, and rare diseases. Although the firm is no longer active as a broker-dealer, its legacy remains through the various life science companies it helped fund and bring to the public markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCO Financial Group.